Osteopontin Protein Drives Cancer Metastasis—New Research Opens Therapeutic Targets
Recent cancer research identifies osteopontin (OPN) as critical driver of tumor metastasis across multiple cancer types. Elevated levels correlate with aggressive tumors; scientists explore osteopontin as therapeutic target and biomarker.